Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: PDI, Inc. | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: PDI, Inc.

Sales services segment revenue for the quarter was $41.4 million (+97%) and for the year was $133.3 million (+82%).

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PDI, Inc.

4Q Revenues: $44.7 million (+94%)

4Q Loss: $2.6 million (loss of $18.4 million in 4Q09)

FY Revenues: $144.7 million (+80%)

FY Loss: $6.8 million (loss of $33.6 million FY09)

Comments: Sales services segment revenue for the quarter was $41.4 million (+97%) and for the year was $133.3 million (+82%). Marketing services revenue for the quarter was $3.3 million and for the year was $11.3 million, down slightly compared to 2009. Results for the quarter includes a $3.1 million operating loss related to the Group DCA acquisition, and for the year includes the operating loss of $4.3 million, comprised of a $0.5 million from legacy PDI and a $3.8 million from the Group DCA acquisition.@font-face { font-family: “Cambria”; }@font-face { font-family: “Optima”; }p.MsoNormal, li.MsoNormal, div.MsoNormal { margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: “Times New Roman”; }div.Section1 { page: Section1; }

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters